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Vitamin E inhibits the UVAI 
induction of “light” and “dark” 
cyclobutane pyrimidine dimers, 
and oxidatively generated DNA 
damage, in keratinocytes
George J. Delinasios1,5, Mahsa Karbaschi2,4, Marcus S. Cooke  2,3,4 & Antony R. Young1
Solar ultraviolet radiation (UVR)-induced DNA damage has acute, and long-term adverse effects 
in the skin. This damage arises directly by absorption of UVR, and indirectly via photosensitization 
reactions. The aim of the present study was to assess the effects of vitamin E on UVAI-induced DNA 
damage in keratinocytes in vitro. Incubation with vitamin E before UVAI exposure decreased the 
formation of oxidized purines (with a decrease in intracellular oxidizing species), and cyclobutane 
pyrimidine dimers (CPD). A possible sunscreening effect was excluded when similar results were 
obtained following vitamin E addition after UVAI exposure. Our data showed that DNA damage by 
UVA-induced photosensitization reactions can be inhibited by the introduction of vitamin E either pre- 
or post-irradiation, for both oxidized purines and CPD (including so-called “dark” CPDs). These data 
validate the evidence that some CPD are induced by UVAI initially via photosensitization, and some 
via chemoexcitation, and support the evidence that vitamin E can intervene in this pathway to prevent 
CPD formation in keratinocytes. We propose the inclusion of similar agents into topical sunscreens and 
aftersun preparations which, for the latter in particular, represents a means to mitigate on-going DNA 
damage formation, even after sun exposure has ended.
The short- and long-term consequences of solar UVR (~295–400 nm) exposure are well-established1 but detailed 
knowledge of the, spectral effects and mechanisms, especially long-term effects, is lacking. The majority (>95%) 
of solar UVR is UVA, most of which (~75%) is UVAI (340–400 nm). This spectral region penetrates the skin 
deeper that UVB (280–320 nm), readily reaching the dermal collagen and elastic fibres2.
The mutagenicity of UVA is caused through induction of DNA damage via direct absorption of UVR by 
DNA, and indirectly via photosensitization reactions3,4. This mutagenicity has been attributed, at least in part, 
to oxidatively generated modification of DNA nucleobases5. One of the most intensively studied lesions is the 
oxidatively modified purine, 8-oxo-7,8-dihydroguanine (8-oxoGua). This lesion is a possible contributor to UVA 
mutagenesis, and its presence has been studied in both epidermal DNA and urine6–8. It has also been proposed 
that UVA may increase intracellular oxidative stress without the generation of additional reactive oxygen species 
(ROS), by increasing the ratio of GSSG/GSH9. Cyclobutane pyrimidine dimers (CPDs) are DNA photolesions that 
have important biological consequences, including mutagenicity, which may lead to keratinocyte cancers of the 
skin10. CPDs also have non-mutagenic consequences such as initiating cytokine release11, and photoimmunosup-
pression that are also thought to be involved in skin cancer12. Importantly, a recent report has demonstrated that 
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UVA exposure of melanin can trigger the formation of CPD via chemically generated, excited electronic states. 
The resulting so-called “dark” CPD, can continue to be formed for at least 3 h after UVA exposure13, in contrast to 
CPD formed immediately upon irradiation (now considered “light” CPD). This phenomenon has been demon-
strated previously in melanocytes, and melanosome recipient keratinocytes in vivo, but not human keratinocytes.
The increasing incidence of skin cancer in sun-sensitive, white-skinned populations has initiated great debate 
on acute and long-term photoprotection. Sunscreens have limitations14 and consequently other methods of pho-
toprotection are being sought. These include the use of various antioxidant substances, although it has often been 
difficult to prove their efficacy for protection of human skin in vivo.
α-Tocopherol (vitamin E) is a well-known antioxidant that is believed to be the most important naturally 
occurring non-enzymatic, lipid-soluble antioxidant in human tissue. Vitamin E can scavenge UVA-induced free 
radicals, protect endogenous epidermal antioxidant degradation and prevent lipid peroxidation, as well as inhibit 
UVR-induced immunosuppression15–17. Vitamin E has been employed in combination with vitamin C revealing 
significant protection against sunburn and erythema, indicating potential protection against skin cancer and 
photoageing18,19. Apart from its free radical scavenging properties, the application of vitamin E prior to UVR 
exposure has attracted attention for its ability to prevent the formation of UVB-induced CPD20. This property has 
been reported in mouse skin in vivo (samples were obtained immediately after UVR), however it is unclear as to 
whether this should be attributed to a sunscreen effect or some other activity of vitamin E21–23, the precise nature 
of which is unclear.
Despite the generally accepted beneficial effects of vitamin E, its photoprotective properties, especially on 
human skin cells, against UVA and UVB irradiation have not been clearly established. The current study was 
undertaken in order to determine the potential for vitamin E to protect against UVAI-induced photolesions, with 
particular emphasis on dark CPDs, in keratinocytes.
Results
Pre-UVAI treatment with vitamin E protects against oxidizing species and DNA damage. Cell 
viability was found to be unaffected by UVAI exposure and/or vitamin E treatment (Table 1). A UVA dose-de-
pendent increase in oxidizing species, determined by H2DCFDA fluorescence, was observed (Fig. 1A). Pre-UVAI 
treatment with vitamin E was found to offer significant protection at all UVAI doses tested. This was demon-
strated at all cases (p < 0.05), with the effect being more evident at higher UVAI doses. The effect was highly sig-
nificant at 40 J/cm2 with a 35% decrease in oxidizing species compared to control (p < 0.001). Vitamin E did not 
alter the level of intracellular oxidizing species in unirradiated cells. Incubating HaCaTs with vitamin E for 24 h, 
prior to irradiation, significantly increased intracellular GSH levels by 2.3-fold (p = 0.002), and protected against 
UVAI-induced GSH depletion (Fig. 1B), suggesting that the UVAI-induced oxidizing species detected above are, 
at least in part, ROS.
Comet analysis in the absence of any enzyme treatment assesses alkali labile sites (ALS) and frank strand 
breaks (SB). Throughout, the comet assay data for oxidized purines and CPD formation were corrected for 
the levels of ALS and SB (ALS/SB background values were subtracted from the corresponding hOGG1- and 
T4endoV-derived values). A UVAI dose-dependent increase in both oxidized purines and CPD formation was 
demonstrated (Fig. 2). Pre-irradiation treatment of HaCaTs with vitamin E offered a statistically significant pro-
tection against UVAI-induced oxidized purines. This effect was observed at both UVAI doses tested (5 and 10 J/
cm2), and was more evident at 5 J/cm2 (66% decrease; p < 0.001). Interestingly, pre-UVA vitamin E treatment was 
found to also inhibit UVAI-induced CPD formation, at both UVAI doses tested (60% and 23% decrease at 5 and 
10 J/cm2, with p < 0.001 and p < 0.01, respectively).
Post-UVAI treatment with vitamin E protects against oxidizing species and DNA damage. A 
time-course study showed that all DNA lesions increased after UVAI exposure (0 h) with a peak of formation at 
1 h (Fig. 3). This was partly expected for oxidized purines and ALS/SB, due to their formation by reactive inter-
mediates, but was surprising for CPD. This reveals the delayed induction of dark CPD in keratinocytes, even after 
removal from UVAI exposure (dotted line), and then their repair, contrasting with the expected repair of CPD 
(dashed line; Fig. 3). The increase and decrease in CPD levels during the 0–2.5 h period was the basis for deter-
mining the time for the post-UVA vitamin E incubations in subsequent studies (i.e. Figs 4 and 5).
Cells treated with vitamin E exhibited lower levels of oxidizing species compared to their untreated coun-
terparts (Fig. 4). This clear protective effect of vitamin E was found to be greater following doses of 20 and 40 J/
cm2 (maximal inhibition of the production of oxidizing species was 38%, at 40 J/cm2; p < 0.05). The post-UVA 
protective effect of vitamin E was also evident on DNA damage. Vitamin E treatment significantly decreased the 
Treatment Viable cells (%) TB Viable cells (%) MTT
Control* 87.3 ± 3.2 88.7 ± 2.5
20 J/cm2 UVAI* 81.8 ± 4.3 80.1 ± 3.6
Vitamin E 88.6 ± 2.5 89.2 ± 2.0
20 J/cm2 UVA + Vitamin E 85.9 ± 1.6 86.5 ± 2.5
Table 1. HaCaT cell viability following UVA ± vit E. Cell viability was assessed by the trypan blue (TB) 
exclusion and the MTT assays. Data represent the mean of three independent experiments ± SEM. One-way 
ANOVA with Bonferroni correction showed significant differences between all groups (p < 0.05). *Cells 
incubated with EtOH for 24 h.
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formation of oxidized purines, compared to non-treated cells (70% and 32% decreases at 5 and 10 J/cm2, with 
p < 0.001 and p < 0.01, respectively) (Fig. 5). Post-UVA vitamin E treatment was also found to decrease CPD 
formation, an observation that cannot be attributed to a possible sunscreen property, since vitamin E was added 
after UVA exposure. CPD values were decreased at both UVA doses tested (52% and 44% decrease at 5 and 10 J/
cm2, with p < 0.05 and p < 0.01, respectively). Induced DNA damage was lower in the post-UVAI incubation 
control experiments compared to incubation pre-UVAI, especially at 5 J/cm2. This suggests DNA repair occurs 
within 2.5 h of exposure.
Vitamin E prevents UVC-induced formation of oxidized purines, but not CPD. Monochromatic 
UVC (254 nm) was employed to assess a possible sunscreening role of vitamin E (see discussion section for 
fuller rationale). As expected; UVC induced high CPD levels, together with some oxidized purines, ALS and SB. 
Incubation with vitamin E pre-UVC led to a significant decrease (Fig. 6) in ALS and SB and oxidized purines 
(66%, p < 0.05) but had no effect on CPD formation.
Discussion
UVAI is by far the major spectral component of solar UVR and penetrates deeper into the skin than UVB. A 
study of DNA damage depth profiles in human skin in vivo shows attenuation of CPD and pyrimidine (6–4) 
pyrimidone photoproduct formation with increasing with skin (epidermis and dermis) depth, but the reverse is 
true, for CPD at least, with UVAI24. This results in greater sensitivity of the keratinocyte stem cell and melanocyte 
containing basal layer to UVAI exposure. UVA-induced mutations are more prevalent in the basal layer than the 
supra-basal layers25. It is therefore important to find new strategies to protect the skin, especially the basal layer, 
from UVAI-induced DNA damage. Vitamin E has been established as a UVR-induced ROS scavenger. To the 
best of our knowledge, we provide the first evidence that UVAI-induced CPD (including dark CPD), as well as 
oxidatively-generated DNA lesions, can be inhibited by vitamin E in HaCaT keratinocytes. Whilst the latter is in 
line with its classical role as an antioxidant, the former is an important finding, given earlier, similar findings, but 
Figure 1. (A) UVAI-induced oxidizing species dose-response in: control (EtOH) or vitamin E (+Vit E) pre-
treated groups; cells were treated with vitamin E for 24 h followed by UVAI irradiation. The production of 
oxidising species was determined by H2DCFDA fluorescence, coupled with flow cytometry. Results represent 
the mean of three independent experiments ±SEM. The UVAI dose-responses were determined by linear 
regression analyses. R2 was >0.98 and slopes were very significantly different from zero (p < 0.0001). (B) Effect 
of vitamin E supplementation on intracellular HaCaT GSH levels. HaCaTs were supplemented with vitamin E 
for 24 h prior to UVAI irradiation. Data are expressed as the means ± SEM of three independent experiments. 
**p < 0.01.
www.nature.com/scientificreports/
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in melanocytes13. Our UVAI doses (5 and 10 J/cm2) were sub-erythemal and physiologically and environmentally 
relevant; a minimal erythema dose (MED) of UVAI is about 50 J/cm2 in fair skin types26.
Carboxy-H2DCFDA was selected to study the formation of oxidizing species because it can be oxidized by 
several UVA-induced reactive oxygen species and free radicals (including H2O2, NO and peroxides)27. The data 
showed a UVAI dose-dependent increase in oxidizing species formation in HaCaT cells. Cells treated with vita-
min E, prior to UVA, produced less oxidizing species compared to controls at all tested doses. Under these same 
conditions, levels of intracellular GSH increased, and subsequently provided some protection against the UVAI 
induction of oxidizing species suggesting that at least some of these oxidizing species are ROS.
Interestingly, a protective effect was also seen when vitamin E was administered post-UVA. It is noteworthy 
that more oxidizing species were generated post- versus pre-UVA incubation. This observation may be attributed 
to the formation of oxidizing species via secondary biochemical pathways28. These species can result from lipid 
peroxidation (which can be inhibited by vitamin E), which in turn might initiate the formation of further oxida-
tively damaged DNA.
The hOGG1-modified comet assay showed that UVAI induced the formation of oxidized purines in 
a dose-dependent manner. Vitamin E offered a significant protective effect with pre- and post-exposure 
incubation. Since the UVA-induced oxidation of purines are formed indirectly, predominantly via the 
Figure 2. Effect of pre-UVAI incubation with vitamin E on the formation of oxidized purines and CPD. Mean 
percentage of tail DNA was determined following UVAI doses of 5 and 10 J/cm2. Results are the mean ± SEM of 
three independent experiments; ***p < 0.001, **p < 0.01 for selected comparisons.
Figure 3. Induction and repair of UVAI-induced oxidized purines and CPDs, determined by the T4endoV- 
and hOGG1-modified comet assay. HaCaT keratinocytes were irradiated with 5 J/cm2 UVA and were left to 
repair for different time periods. At 0 h, the dotted line mainly represents the formation of “light” CPD. The 
subsequent increase, with a peak at 1 h, represents the formation of “dark” CPD and their repair (1–2.5 h). The 
dashed line, which joins the dotted line, represents the proposed, differential repair of “light” CPD. The results 
are the mean ± SEM of three independent experiments.
www.nature.com/scientificreports/
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photosensitizer-dependent induction of 1O229,30, the antioxidant/scavenging properties of vitamin E were not 
surprising, although this protective effect has not previously been demonstrated for oxidized purines by the 
comet assay, especially with post-UVAI incubation. This suggests that, after the initial ROS generation via pho-
tochemical processes (energy transfer to molecular oxygen, electron abstraction, etc), biochemical pathways are 
then responsible for the generation of secondary ROS, possibly through 1O2 production31,32. This may occur via 
UVA-induced enzyme activity, e.g. activation of NADPH oxidase28. NADPH oxidase increases UVA-induced 
superoxide, in mouse, monkey and human cell lines33, which can be converted to other ROS. Other studies show 
evidence of a protective effect of vitamin E against ovulation-induced 8-oxoGua in ovarian epithelial cells34, 
as well as ozone-induced 8-oxoGua35. The antioxidant role of vitamin E has been reported to protect against 
cis-urocanic acid-induced ROS36. It is worth noting that 1O2 does not generate strand breaks, although some 
alkali-labile sites (both of which may be evaluated by the comet assay) can be produced (as noted in Cooke et al.37, 
but predominantly it is the nucleobase modification, 8-oxoGua, that is generated38.
CPDs, assessed by the T4endoV-modified comet assay, were readily induced by UVAI irradiation, and their 
formation was significantly inhibited by incubation with vitamin E before and after irradiation. The ability of 
Figure 4. UVAI-induced oxidizing species dose-response in: control (EtOH) or vitamin E (+Vit E) treated 
groups; cells were treated with vitamin E for 2.5 h, after UVA irradiation. Production of oxidising species was 
determined by H2DCFDA fluorescence. Results represent the mean of three independent experiments ± SEM. 
The UVA dose-responses were determined by linear regression analyses. R2 was >0.92 and slopes were very 
significantly different from zero (p < 0.0001).
Figure 5. Effects of post-UVAI incubation on oxidized purine and CPD formation. Mean percentage of tail 
DNA was determined following UVA doses of 5 and 10 J/cm2 and treatment of cells with vitamin E for 2.5 h. 
Results are the mean ± SEM of three independent experiments; ***p < 0.001, **p < 0.01, *p < 0.05 for selected 
comparisons.
www.nature.com/scientificreports/
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post-UVAI vitamin E incubation to inhibit CPD excludes a sunscreening effect, but also alludes to an indirect 
mechanism for UVAI-induced CPD. This is supported by the irradiation studies with UVC (254 nm), which is 
close to the action spectrum maximum for CPD induction in vitro39. Action spectroscopy shows that produc-
tion of CPD at 300–310 nm is three orders of magnitude lower than at 254 nm40. Figure 6 shows that 254 nm 
induced high levels of CPD as well as oxidized purines. Although UVC-induced 8-oxoGua has been previously 
reported41–43 there is little literature on UVC-induced cellular oxidative stress. One report has suggested that 
UVC-induced 8-oxoGua formation is via 1O230, although it is not clear how this would occur, and the involvement 
of guanine radical cations are perhaps a more likely mechanism44. Pre-UVC incubation with vitamin E signifi-
cantly protected against the formation of oxidized purines but not against CPD (Fig. 6). As can be seen in Fig. 7, 
vitamin E absorption at 254 and ~300 nm is similar, but higher than at longer wavelengths in the UVAI source. 
Thus, one might expect a comparable or better sunscreening effect for CPD at 254 nm than with UVAI. The lack 
of such an effect for CPD suggests that protection against the formation of oxidized purines is via mechanisms 
Figure 6. Effect of vitamin E pre-incubation on UVC-induced formation of CPD and oxidized purines, 
determined by T4endoV- and hOGG1-modified comet assays, respectively. The results represent mean (±SEM) 
percentage tail DNA in HaCaT cells exposed to UVC for 10 s, and have been corrected for baseline levels of 
damage and SB/ALS. Results are the mean ± SEM of three independent experiments; *p < 0.05 for selected 
comparisons.
Figure 7. Emission spectrum of the “UVA spot”. This was determined by a Bentham DM150 double 
monochromator spectroradiometer through the plastic lid of a petri dish in which cells were irradiated, at a 
distance of 39 cm. Also shown is the absorption spectrum of a vitamin E solution (0.1 mg/mL in ethanol).
www.nature.com/scientificreports/
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other than sunscreening. Furthermore, the action spectrum for 8-oxoGua formation shows a peak in the UVAI 
(λmax = 365 nm) region40, although UVB may also induce this lesion7. We recognize that the very small UVB 
content (0.1%) of our UVAI source (Table 2) may have caused a disproportionally large number of CPD45 but the 
complete lack of effect of vitamin E on UVC-induced CPD supports a different mechanism for UVAI-induced 
CPD.
CPDs are formed mainly via direct photon absorption by DNA in the UVC and UVB regions. DNA shows some 
direct UVA absorption46 which is well established to result in CPD formation in vitro and in vivo, in cellular47–51, 
and naked DNA4,51–56, and is likely to represent the main pathway for the majority of CPD formation, with UVAI 
inducing CPD at a ratio of 87:9:4 for T <  > T, T <  > C and C <  > C, respectively50. However, UVA-induced CPD 
may also be formed by photosensitization, and chemiexcitation reactions in vitro as with carprofen57 and mela-
nin13. In this case the photosensitizer is converted to its triplet state, the energy of which, if high enough, is trans-
ferred to DNA to generate CPD58. Therefore, unidentified endogenous photosensitizers, which we have proposed 
may possess structural similarities to pyridopsoralens59,60, might play a role in UVAI-induced CPD formation in 
keratinocytes, especially in the more complex in vivo system. Our data suggest that vitamin E may quench the tri-
plet state of a putative sensitizer. However, since similar levels of CPDs are induced by UVA in cellular and naked 
DNA, this53,54,61 suggests that triplet energy transfer may be a minor process. Our results in cultured keratinocytes 
indicate that there is an ~20% increase in CPD in the 1 h after removal from UVAI exposure.
UVA-induced lipofuscin in HaCaTs has been reported to be a photosensitizer for subsequent exposure (48 h 
later) to visible radiation, which results in the formation of oxidatively induced damage to DNA62. Although we 
did not measure visible radiation this was clearly present in our source (Fig. 7) especially in the violet region 
(400–450 nm), which is reported to be very effective in the generation of 1O2 from lipofuscin63. On this basis, it 
is possible that lipofuscin might be the unknown photosensitizer that is responsible for the ROS generation, and 
formation of oxidized purines and ALS in our study. However, we lack data on the lipofuscin triplet energy level 
so it is not possible to say whether or not lipofuscin could generate CPD by a sensitization reaction.
A comparison of the comet assay data from the pre- and post-UVA vitamin E incubation studies (Figs 2 and 5) 
suggests some repair of oxidized purines and CPD during the 2.5 h post-UVA period. This was confirmed in 
time-course studies with 5 J/cm2 (Fig. 3) that showed a t1/2 of about 4 h for both lesions (achieving a maximum at 
1 h). This is similar to the t1/2 of ~4.5 h reported for UVA-induced CPD in HaCaTs in a recent publication from 
our group64. However, the t1/2 for oxidized purines in the current study is faster than that of about 10 h in our pre-
vious study, in which we also showed that DNA repair kinetics were dependent on UVR spectrum. The times for 
t1/2 are of course longer when using 0 h as a reference point. It should also be noted that very different UVA spectra 
were used in the two studies. Our present time-course study demonstrates the formation of “dark DNA photole-
sions”, that have been recently reported for CPD in melanocytes13 but not for oxidatively-induced DNA lesions.
It is possible that vitamin E incubation post-UVAI exposure decreases CPD by enhancing their repair by 
inhibiting ROS65 which, along with RNS, can damage/inhibit DNA repair enzymes and DNA polymerases (asso-
ciated with both nucleotide excision repair (NER) and base excision repair (BER)66,67. This concept is supported 
by studies that show that post-UVA treatment with vitamin D3 suppresses nitric oxide products resulting in 
enhanced DNA repair; with a consequent reduction of CPD, immunosuppression and photocarcinogenesis68. 
UVA induces oxidatively-generated crosslinking (through 1O2 production) between the subunits of the replica-
tion and repair protein, PCNA69. Furthermore, UVA-induced ROS are also known to activate several MAPKs70, 
therefore, by affecting various downstream effectors, such as AP-1 and NFκB, they may alter DNA repair 
responses, cell cycle arrest or apoptosis71. One study showed that vitamin E treatment post-UVR (broad spec-
trum) irradiation increased CPD repair in mouse skin in vivo and this result was correlated with decreased p53 
protein levels72.
In the present study, we showed that vitamin E can inhibit UVAI-induced oxidizing species production and 
induction of DNA damage, even when human keratinocytes are treated after irradiation. Whilst perhaps better 
established for ROS-induced DNA damage, the important implication of this is that the process of CPD forma-
tion continues after irradiation has ended, implying a mechanism similar to that seen in melanocytes13,73. Several 
questions remain about the chemistry behind the protection offered by vitamin E, and it is important to establish 
whether similar protection levels can be demonstrated in human skin.
Spectral Region Wavelength (nm) % of total irradiance % EEE
UVA 321–400 99.8 87.5
UVAI 340–400 97.5 78.4
UVAII 321–340 2.3 9.1
UVB (CIE)* 281–315 0.1 10.4
UVB 281–320 0.2 12.7
UVC 200–280 0.0 0
Total UVR 200–400 100 100
Table 2. Spectroradiometric distribution of the emission spectrum (see Fig. 1) of the UVAspot (measured 
through the plastic lid of a 6-well plate used in the experiments), and their respective erythemally effective 
energies (EEE), obtained by multiplying with the CIE action spectrum for erythema25. This shows that the 
majority of the EEE was in the UVAI region. *Official CIE definition of UVB, but a cut-off at 320 nm is used in 
dermatology research.
www.nature.com/scientificreports/
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An ideal sunscreen protects against UVR-induced, direct and indirect DNA damage, together with oxidative 
stress, and erythema. Our data, and those from other groups4,54,74–76, support the addition of antioxidants to 
sunscreens and after-sun preparations. Although relatively small, our demonstration of ‘dark’ CPD formation in 
keratinocytes, in the absence of melanin, indicates that such preparations should also contain agents which are 
both antioxidants and, for completeness, triplet state quenchers to decrease the formation of CPD in skin, which 
continues even after sunlight exposure has ended.
Figure 3 shows the induction and repair of CPD. The delayed, secondary increase, peaking at 0.5–1 h after the 
end of the UVR exposure, is very similar to that reported by Premi et al.13 for “dark” CPD. Whilst it is not pos-
sible to distinguish between ‘dark” CPD and the formation of those from direct UVR absorption (“light” CPD), 
we speculate that CPD burden at time 0 h primarily represents the latter and that the peak at 0.5–1 h represents 
the addition of “dark” to “light” CPD. We further speculate that there two overlapping CPD repair kinetics in 
Fig. 3. The dashed line from 0 to 2.5 h, and continuing to the dotted line, mainly reflect the typical NER kinetics 
of “light” CPD that is relatively slow with a half-life of 33.3 h in human epidermis in vivo77, but the rapid decline 
from the peak to the 3 h timepoint suggests a different, faster repair process for the “dark” CPD, more akin to 
the kinetics of the pyrimidine (6–4) pyrimidone photoproduct, with a half-life of 2.3 h in human epidermis in 
vivo77. Although fast repair of CPD, under particular conditions, is not without precedent64. The reasons for these 
differences remain to be elucidated. “light” and “dark” CPD may have different preferential nucleobases locations 
or properties that differentially activate NER. For example, “dark” CPD are reported to include a higher ratio of 
cytosine-containing (T <  > C and C <  > T), to thymine-thymine CPD13 and cytosine-containing CPD are more 
rapidly repaired78. It is clear that “dark” CPD remain an intriguing phenomenon, and about which there is no 
doubt much more for us to learn.
Materials and Methods
Cell culture and vitamin E treatment. The HaCaT cell line (spontaneously immortalized keratinocytes) 
was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Paisley, UK) supplemented with 10% fetal calf serum 
(Sigma-Aldrich, Poole, UK), 100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen) and maintained at 
37 °C in 95% air/5% CO2. Vitamin E (D-α-tocopherol; Sigma-Aldrich, Poole, UK) concentration was fixed at 
0.1 mM for all experiments. The experimental procedure was designed to include two treatment protocols. Cells 
were either treated with vitamin E for 24 h prior to UVA irradiation (pre-UVA treatment), or treated for 2.5 h after 
irradiation under the incubation conditions described above. Various post-UVA incubation times were tested in 
pilot studies and this time period was selected as the shortest period with a significant effect on both oxidized 
purines and CPD (data not shown).
Irradiation and dosimetry. The UVAI source used was a UVASPOT (400/T, Dr K Hönle UVTechnologie, 
Munich, Germany), the spectrum of which is shown in Fig. 7, and described in Table 2. The erythemal effec-
tive energy (EEE) was calculated using the erythemal action spectrum of the International Commission on 
Illumination (CIE)79. Irradiance was determined with an International Light IL 442 A radiometer (Newbury 
Port, MA, USA) with a UVA detector calibrated against the measurements made with a double-monochromator 
spectroradiometer (Bentham Instruments, Reading, UK), which was calibrated against a UK national stand-
ard. Experiments to exclude any sunscreening effect of vitamin E were carried out with UVC (254 nm) using an 
XX-15s UV Bench Lamp (UVP, Cambridge, UK).
Cell irradiation (in monolayers) was performed at 17 cm from the UVAI source, in PBS and a maximum 
irradiation dose was fixed at 40 J/cm2. Comet assay experiments were accrued out with UVAI doses of 5 and 10 J/
cm2, while for the oxidizing species detection assay doses of 10, 20 and 40 J/cm2 were used. As the UVAI source 
produced high levels of heat, a cooling platform was used at 6 °C that kept the cells at ~27 °C. Cells were kept on 
ice after irradiation/treatment before any processing. Control (unirradiated) cell cultures were maintained under 
the same conditions. UVC irradiation was performed at a distance of 25 cm from the lamp. Exposure was based 
on time (10 and 20 s), and determined empirically.
Spectroscopy. UVR absorbance of vitamin E (0.1 mg/mL in ethanol) was determined with a UV/Vis 
Spectrophotometer (ATI Unicam, UK) between wavelengths 250–340 nm, to assess for a possible sunscreening 
effect. An overlap between the emission spectrum of the UVAspot and the vitamin E absorption spectrum can be 
observed in the 300–320 nm UVB region (Fig. 7).
Cell viability. Twenty-four hours after UVAI exposure or vitamin E treatment, cell viability was determined 
using both the trypan blue exclusion assay, and the MTT assay, to ensure the absence of any significant cytotox-
icity. Trypan blue (Sigma-Aldrich, Poole, UK) (0.04% final concentration) was added to cell suspensions and 
cells were counted in a haemacytometer. For the MTT assay, aliquots (20 μL) of MTT solution (10 mg/mL PBS) 
were added to the cells, and incubated for 4 h at 37 °C. After this, 100 μL of lysis solution (0.04 M HCl in absolute 
isopropanol) were added, and the cells shaken for approximately 10 min. The plates were subsequently read on a 
plate reader at 550 nm.
Measurement of oxidizing species. We aimed to evaluate total intracellular ROS generation was detected 
using 5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA; Invitrogen, Paisley, 
UK). The reliability of this approach to measure intracellular H2O2 and ROS has been called into question, 
and a number of caveats need to be considered. Specifically, oxidizing species other than ROS may also oxidize 
carboxy-H2DCFDA to form a fluorescent product80 we acknowledge this caveat and use the term “oxidizing 
species” accordingly.
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After UVAI exposure, 2 mL of 5 μM carboxy-H2DCFDA, diluted in PBS (containing 1 g/L glucose; Gibco) 
were added to cell suspensions (PBS-only was added in control samples). Cells were incubated for 20 min, in the 
dark, at 37 °C in a humidified incubator with 95% air/5% CO2. Plates were subsequently washed twice with PBS 
to completely remove any dye not internalized by the cells.
For the pre-UVR vitamin E incubation experiments, cells were analyzed immediately following irradia-
tion. Following trypsinisation, cells were centrifuged at 400 × g for 4 min at 4 °C and resuspended in 0.5 mL 
of PBS + 0.1% (w/v) bovine serum albumin (BSA). Samples were then transferred to FACS tubes and ana-
lyzed with a Becton Dickinson FACSAria II instrument (BD Biosciences, San Jose, USA), using the FL1 chan-
nel (green fluorescence). The viable portion of the cell population was quantified by addition of 2.5 μg/mL 
propidium iodide (PI) immediately before the analysis. Cells were then subjected to analysis by flow 
cytometry.
Total glutathione measurement. Intracellular concentrations of reduced glutathione (GSH) were deter-
mined using the GSH/GSSG kit (Calbiochem, La Jolla, CA,USA). Cell pellets were homogenized in 50 µL of cold 
metaphosphoric acid (5% w/v) and resuspended in a total volume of 500 µL. The homogenate was centrifuged for 
10 min (3,000 × g) at 4 °C, before 100 µL of supernatant was combined with the kit, and analysed using a UV-vis 
spectrophotometer.
Measurement of DNA damage by the comet assay. DNA damage was assessed using the alka-
line comet assay with specific protocol modifications, according to the type of damage investigated. 
Oxidatively-induced DNA damage was measured using the human 8-oxoguanine DNA glycosylase 1 
(hOGG1)-modified comet assay. hOGG1 recognizes 8-oxoGua, together with 2,6-diamino-4-hydroxy-5-f
ormamidopyrimidine81, with minimal activity towards 4,6-diamino-5-formamidopyrimdine82. On this 
basis, and as previously64, we have used the term “oxidised purines” to describe the damage recognized by the 
hOGG1-modified comet assay. CPDs were assessed using the T4 endonuclease V (T4endoV)-modified comet 
assay, as described elsewhere64. As we have noted previously64, there are no specific data concerning the preferen-
tial activity of T4endoV towards the potential combinations of pyrimidines in CPD. However, inferences can be 
made from the ability of the enzyme to incise at all combinations of CPD, in plasmids and small bacteriophage 
vectors, suggesting all are equal substrates.
Cells were counted before UVR exposure and distributed in the wells of a 9-well plate (~103 cells per well). 
After irradiation, cells were collected and centrifuged at 400 × g for 4 min, at 4 °C. The supernatant was discarded 
and pellets were kept on ice. Cells were mixed with 200 μL of low-melting point agarose and 75 μL of the gel was 
quickly poured onto slides pre-coated with agarose. Coverslips were placed over the gels, and the slides were kept 
on a tray on ice for 10 min to allow the agarose to set. Coverslips were then removed and the slides were placed 
in a tank filled with lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM acid Tris, 1% sodium sarcosinate, pH 10, 1% 
Triton X-100, and 10% dimethyl sulphoxide) for 16 h at 4 °C, in the dark.
After removing the lysis buffer, slides were washed with ice-cold ddH2O for 10 min (in the dark, to prevent 
adventitious DNA damage). Slides were immersed twice in enzyme reaction buffer (40 mM Hepes, 0.1 M KCl, 
0.5 mM EDTA, 0.2 mg/mL BSA, pH 8), for 5 min each, at room temperature. T4endoV (0.1 U/mL), or hOGG1 
(3.2 U/mL), or enzyme reaction buffer alone, was added to each gel (both enzymes were purchased from New 
England Biolabs, Hitchin, UK). Coverslips were placed on top of the gels to ensure equal distribution of the 
enzymes, and slides were incubated at 37 °C in a humid atmosphere for 45 min. Slides were subsequently trans-
ferred to ice-cold electrophoresis buffer (NaOH 10 M, EDTA 200 mM, pH 13 in ddH2O) and incubated for 20 min 
in the dark. Electrophoresis was then performed for 20 min at 25 V, 300 mA.
Finally, slides were rinsed with neutralization solution (0.4 M Trizma Base, pH 7.5; Sigma) for 20 min and 
then washed with ddH2O for 10 min. Slides were allowed to dry at room temperature overnight. DNA was stained 
using 1 mL of propidium iodide solution at 2.5 μg/mL in PBS per slide for 20 min. Slides were then washed with 
ddH2O for 20 min. After drying, slides were examined at a magnification of 40×, using a Zeiss Axiophot epiflu-
orescence microscope (Carl Zeiss, Germany) equipped with a green excitation filter. Images of the whole of each 
slide were taken with a Nikon camera linked to the microscope. Fifty randomly selected cells per gel and three 
Figure 8. Representative images of (A) hOGG1-modified comet assay analysis of untreated cells; (B) hOGG1-
modified comet assay analysis of cells treated with 10 J/cm2 UVA; (C) hOGG1-modified comet assay analysis 
of cells treated with 10 J/cm2 UVA, with post-irradiation with vitamin E; (D) T4endoV-modified comet assay 
analysis of cells treated with UVC for 10 s; and (E) T4endoV-modified comet assay analysis of cells treated with 
UVC for 10 s, after pre-incubation with vitamin E.
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gels per condition were analysed (n = 150) using Comet Score (TriTek Corp., Summerduck, VA, USA). The per-
centage tail DNA (%DNA) was measured for each nucleoid body scored.
Representative images of comets are shown in Fig. 8.
Statistical analysis. All experiments were conducted in triplicate and values are presented as mean ± stand-
ard error of the mean (SEM). Comet assay values were compared for statistical significance with the Mann–
Whitney non-parametric test. For the measurement of oxidizing species, a Student’s t-test was used to determine 
the degree of statistical significance between values from different experimental groups; results were plotted. All 
analyses and graphs were performed using the GraphPad Prism 6 software (GraphPad Software Inc., San Diego, 
CA, USA). Statistical significance was defined as p < 0.05.
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